MedCity News
Another Phase III study finds hydroxychloroquine ineffective
[H]ydroxychloroquine – the malaria and autoimmune disease drug that President Donald Trump promoted as a potential “game changer” early in ...
Why use gene editing on human embryos when other options are available?
Researchers in the U.S. and South Korea have shown that gene editing can correct a genetic disorder in an embryo. Using CRISPR-Cas9, ...
Why CRISPR, other academia-produced technologies, should belong to everyone
Why does anybody own CRISPR? [According to Michael Eisen, Berkeley professor and co-founder of the Public Library of Science] intellectual property in ...
Nanotechnology could lead to revolution in drug development
Monoclonal antibody research skyrocketed in the 1980s. By the next decade, they hit the market and today, some of the ...